Cell culture processes for the production of viral vectors for gene therapy purposes

被引：17

作者：

Warnock, James N.

Merten, Otto-Wilhelm

Al-Rubeai, Mohamed ^{[1
]}

机构：

[1] Univ Coll Dublin, Sch Chem & Bioproc Engn, Dublin 4, Ireland

[2] Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA

[3] Genethon, F-91002 Evry, France

来源：

CYTOTECHNOLOGY | 2006年 / 50卷 / 1-3期

关键词：

adeno-associated virus; adenovirus; bioreactor; culture conditions; herpes simplex virus vectors; lentivirus; microcarrier; optimization; process development; retrovirus;

D O I：

10.1007/s10616-005-5507-z

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Gene therapy is a promising technology for the treatment of several acquired and inherited diseases. However, for gene therapy to be a commercial and clinical success, scalable cell culture processes must be in place to produce the required amount of viral vectors to meet market demand. Each type of vector has its own distinct characteristics and consequently its own challenges for production. This article reviews the current technology that has been developed for the efficient, large-scale manufacture of retrovirus, lentivirus, adenovirus, adeno-associated virus and herpes simplex virus vectors.

引用

页码：141 / 162

页数：22

共 50 条

[21] Viral vectors for gene transfer to striated muscle
Gregorevic, P
Blankinship, MJ
Chamberlain, JS
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (05) : 491 - 498
[22] Adeno-associated viral vectors: methods for production and purification for gene therapy applications
Mena-Enriquez, Mayra
Flores-Contreras, Lucia
Armendariz-Borunda, Juan
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2012, 64 (05): : 487 - 494
[23] Viral vectors for in vivo gene transfer in Parkinson's disease:: Properties and clinical grade production
Mandel, Ronald J.
Burger, Corinna
Snyder, Richard O.
EXPERIMENTAL NEUROLOGY, 2008, 209 (01) : 58 - 71
[24] T cell responses in experimental viral retinitis: Mechanisms, peculiarities and implications for gene therapy with viral vectors
Zinkernagel, Martin S.
McMenamin, Paul G.
Forrester, John V.
Degli-Esposti, Mariapia A.
PROGRESS IN RETINAL AND EYE RESEARCH, 2011, 30 (04) : 275 - 284
[25] Unlocking effective transgene expression potential in gene therapy with viral vectors
Halim, Nur Shuhaidatul Sarmiza Abdul
Abu Halim, Noor Hanis
Vengidasan, Lelamekala
Zakaria, Norashikin
Ismail, Ida Shazrina
Yahaya, Badrul Hisham
BIOMEDICAL RESEARCH AND THERAPY, 2021, 8 (10): : 4596 - 4611
[26] Immune response and gene therapy with adenoassociated viral vectors
Sierra-Delgado, Julieth A.
Bautista-Nino, Paula K.
Vargas-Castellanos, Clara, I
Serrano Diaz, Norma C.
Rincon, Melvin Y.
MEDICINA-BUENOS AIRES, 2019, 79 (06) : 493 - 501
[27] Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma
Mozhei, Oleg
Teschemacher, Anja G.
Kasparov, Sergey
CANCERS, 2020, 12 (12) : 1 - 23
[28] Viral vectors for gene delivery to the central nervous system
Lentz, Thomas B.
Gray, Steven J.
Samulski, R. Jude
NEUROBIOLOGY OF DISEASE, 2012, 48 (02) : 179 - 188
[29] The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
Mata-Espinosa, Dulce
Lara-Espinosa, Jacqueline V.
Barrios-Payan, Jorge
Hernandez-Pando, Rogelio
PHARMACEUTICALS, 2023, 16 (10)
[30] Challenges in downstream purification of gene therapy viral vectors
Singh, Nripen
Heldt, Caryn L.
CURRENT OPINION IN CHEMICAL ENGINEERING, 2022, 35

← 1 2 3 4 5 →